Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2023-12-18 00:00:00 ET · period of report 2023-09-12 · accession 0000935836-23-000733 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-12-18 | 2023-09-12+ | OLMA | Graham G. Walmsley | Dir | P - Purchase | $10.74 | +640.0K | 1.67M | +62% | +$6.87M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-05 | P | A | 50,000 | $13.09 | 1,800,000 | I See note | — | — | (F1) The shares are held by Logos Global Master Fund LP ("Logos Master Fund"). Logos GP LLC ("Logos GP") is the general partner of Logos Master Fund and the reporting person is a managing member of Logos GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. |
| 2 | Common | Common Stock | 2023-12-05 | P | A | 50,000 | $14.95 | 1,750,000 | I See note | — | — | (F1) The shares are held by Logos Global Master Fund LP ("Logos Master Fund"). Logos GP LLC ("Logos GP") is the general partner of Logos Master Fund and the reporting person is a managing member of Logos GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. |
| 3 | Common | Common Stock | 2023-12-05 | P | A | 31,870 | $14.73 | 1,700,000 | I See note | — | — | (F1) The shares are held by Logos Global Master Fund LP ("Logos Master Fund"). Logos GP LLC ("Logos GP") is the general partner of Logos Master Fund and the reporting person is a managing member of Logos GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. |
| 4 | Common | Common Stock | 2023-09-12 | P | A | 508,130 | $9.84 | 1,668,130 | I See note | — | — | (F1) The shares are held by Logos Global Master Fund LP ("Logos Master Fund"). Logos GP LLC ("Logos GP") is the general partner of Logos Master Fund and the reporting person is a managing member of Logos GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. |